Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Belluscura PLC ( (GB:BELL) ) is now available.
Belluscura PLC has announced its intention to appoint an administrator following unsuccessful refinancing discussions with the Omaha Investor Group. The company’s US subsidiary, Belluscura LLC, has filed for Chapter 7 Bankruptcy, leading to a default on convertible loan notes amounting to £9.17m, which the company cannot repay. Consequently, Belluscura’s Nominated Adviser, SPARK Advisory Partners Limited, has resigned, and the company does not plan to appoint a replacement, risking the cancellation of its AIM trading admission.
More about Belluscura PLC
Belluscura PLC is a UK-based medical device company that specializes in developing oxygen enrichment technology for various industries and therapies.
Technical Sentiment Signal: Strong Sell
Current Market Cap: £3.01M
For an in-depth examination of BELL stock, go to TipRanks’ Overview page.